caffeine has been researched along with Hepatopulmonary Syndrome in 1 studies
Hepatopulmonary Syndrome: A syndrome characterized by the clinical triad of advanced chronic liver disease, pulmonary vascular dilatations, and reduced arterial oxygenation (HYPOXEMIA) in the absence of intrinsic cardiopulmonary disease. This syndrome is common in the patients with LIVER CIRRHOSIS or portal hypertension (HYPERTENSION, PORTAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC | 1 |
| Chuang, CL | 1 |
| Tsai, MH | 1 |
| Hsin, IF | 1 |
| Hsu, SJ | 1 |
| Huang, HC | 1 |
| Lee, FY | 1 |
| Lee, SD | 1 |
1 other study available for caffeine and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Effects of Caffeine Treatment on Hepatopulmonary Syndrome in Biliary Cirrhotic Rats.
Topics: Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Caffeine; Disease Models, Animal; Hepato | 2019 |